TRIM24 is associated with both oncogenic and tumor suppressive effects; deletion of TRIM24 promotes hepatocellular carcinoma in mice, while overexpression negatively correlates with cancer progression, including breast and prostate cancers21–23. This evidence concerns the gene TRIM24 and hepatocellular carcinoma.